NL-OMON47991尚未招募不适用
Adoptive Transfer of T cell Receptor-engineered T cells to treat hepAtocellular Carcinoma recurrence after liver Transplantation: a preclinical feasibility study - ATTRACT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients diagnosed with autoimmune hepatitis
- •- Age: 18 years or older
- •- Written informed-consent
排除标准
- •- Patients with current use of immune suppressive agents/medication, not other
- •- Patients with an immunocompromised medical condition, not other specified
- •- Patients who refuse to participate in the study (refusing blood donation)
- •- Patients that for medical reasons are judged unfit to donate blood by the
- •treating physicians
研究者
相似试验
招募中
不适用
Adoptive therapy with TCR gene-engineered T cells to treat patients with MAGE-C2-positive melanoma and head and neck cancer.head and neck squamous cell carcinomamaligne melanomauveal melanoma100300541002765610040900skin cancerNL-OMON52657Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
2 期
MAGE-C2 TCR T cell therapy2024-516922-70-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)20
已完成
1 期
Adoptive transfer of autologous T cells followed by vaccination with MAGE-A4-derived peptides after chemotherapy for MAGE-A4-expressing advanced cancer patientsHead and neck cancer, Ovarian cancer, Esophageal cancer, Multiple myelomaJPRN-UMIN000001063Department of Immuno-gene Therapy, Mie University Graduate School of Medicine9
招募中
不适用
Evaluation of Transplant-reactive T cells for the Prediction or Diagnosis of Transplant Rejection in Kidney Transplant Recipients (TreaT-Assay)T86.10T86.11T86.12T86.19DRKS00028707Charité Campus Virchow-Klinikum185
招募中
不适用
Donor leukapheresis for T-cell receptor gene therapy for treatment of metastatic melanoma (skin cancer)10040900melanomaSkin cancerNL-OMON34342ederlands Kanker Instituut2